Trends in the development of chiral drugs

被引：334

作者：

Caner, H ^{[1
]}

Groner, E

Levy, L

Agranat, I

机构：

[1] Hebrew Univ Jerusalem, Dept Organ Chem, IL-91904 Jerusalem, Israel

[2] Univ London Imperial Coll Sci Technol & Med, Fac Med, Div Biomed Sci, London SW7 2AZ, England

来源：

DRUG DISCOVERY TODAY | 2004年 / 9卷 / 03期

关键词：

D O I：

10.1016/S1359-6446(03)02904-0

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：105 / 110

页数：6

共 20 条

[1] Putting chirality to work: The strategy of chiral switches [J].

Agranat, I ;

Caner, H ;

Caldwell, A .

NATURE REVIEWS DRUG DISCOVERY, 2002, 1 (10) :753-768

[2] Intellectual property and chirality of drugs [J].

Agranat, I ;

Caner, H .

DRUG DISCOVERY TODAY, 1999, 4 (07) :313-321

[3]

[Anonymous], 2003, STEREOCHEMICAL ASPEC, DOI 10.1016/s0065-2490(96)80003-7

[4]

BRISTOL JA, 1984, ANNU REP MED CHEM, P19

[5]

Caldwell J., 1999, MODERN DRUG DISCOV, V2, P51

[6]

*COMM PROPR MED PR, 1993, III350191 COMM PROPR

[7]

Eichelbaum M., 1996, ADV DRUG RES, V28, P1, DOI 10.1016/S0065-2490(96)80003-7

[8]

Food & Drug Administration, 1992, FED REGISTER, V57, P22249

[9]

Hilts P. J., 2003, PROTECTING AM HLTH F, P144

[10]

MILLER SP, 2001, 13 INT S CHIR DISCR

← 1 2 →